beta-aminoethyl isothiourea has been researched along with Lymphoma, Non-Hodgkin in 2 studies
beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ALTENBRUNN, HJ | 2 |
HUBER, R | 1 |
2 other studies available for beta-aminoethyl isothiourea and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
[THE INFLUENCE OF CYSTEAMINE AND AET ON OXIDATIVE PHOSPHORYLATION OF IRRADIATED LYMPHOSARCOMA IN AN ASCITIC FORM].
Topics: beta-Aminoethyl Isothiourea; Cysteamine; Lymphoma, Non-Hodgkin; Metabolism; Mice; Mitochondria; Neop | 1964 |
EXPERIMENTS ON INFLUENCEING THE RADIO-SENSITIVITY OF ANIMAL TUMOURS BY SH-COMPOUNDS.
Topics: beta-Aminoethyl Isothiourea; Carcinoma; Carcinoma 256, Walker; Cytochromes; Lymphoma; Lymphoma, Non- | 1964 |